Cell & Gene Therapy Conferences
Cell & Gene Therapies continue to redefine what is possible across oncology, rare disease, autoimmune disorders, and beyond, building on a growing body of clinical and commercial success while expanding into increasingly complex indications.
As the industry matures, the challenge is no longer proving the science. Developers are focussed on translating breakthrough innovation into scalable, accessible, and commercially viable therapies, while navigating manufacturing complexity, regulatory evolution, reimbursement pressures, and a more selective, capital-constrained investment landscape.
Innovation is accelerating across in vivo approaches, gene editing and next-generation delivery technologies that promise to overcome the limitations of traditional ex vivo manufacturing, combined with continued progress in automation, process development, and platform technologies. These breakthroughs are shaping the future of how cell and gene therapies are developed, manufactured, and accessed worldwide, unlocking more efficient paths from scientific breakthrough to patient impact.